Low-frequency and very low-intensity ultrasound decreases blood pressure in hypertensive subjects with type 2 diabetes

      Abstract

      Background

      Despite lifestyle interventions and various types of anti-hypertension agents, hypertension remains difficult to control in some patients with type 2 diabetes. As a noninvasive device-based approach for the treatment of clinic hypertension, we examined the effects of low-frequency and low-intensity ultrasound (500 or 800 kHz, 25 mW/cm2) applied to the forearm on blood pressure (BP) and pulse rate in Japanese subjects with type 2 diabetes and hypertension.

      Methods

      We examined the effects of low-frequency and low-intensity ultrasound (500 or 800 kHz, 25 mW/cm2) applied to the forearm on BP, pulse rate, and pulse pressure in 212 Japanese subjects (82 men and 130 women; mean age ± SE, 65 ± 1 years) with type 2 diabetes and hypertension (systolic BP > 140 mmHg). The subjects were treated with anti-hypertension agents.

      Results

      Systolic and diastolic BP, pulse rate, pulse pressure in the 800-kHz ultrasound treatment group were significantly lower than the baseline values in hypertensive subjects with type 2 diabetes, and lower than those of placebo controls. In addition, systolic and diastolic BP, pulse rate, and pulse pressure in the 500-kHz ultrasound treatment group were significantly lower than the baseline values in hypertensive subjects with type 2 diabetes, and systolic BP, pulse rate, and pulse pressure were significantly lower than those of placebo controls.

      Conclusions

      Low-frequency (800 kHz or 500 kHz) and low-intensity (25 mW/cm2) ultrasound irradiation to the forearm might have potential usefulness as a therapeutic application for clinic hypertension in subjects with type 2 diabetes.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Emdin C.A.
        • Rahimi K.
        • Neal B.
        • Callender T.
        • Perkovic V.
        • Patel A.
        Blood pressure lowering in type 2 diabetes. A systemic review ad meta-analysis.
        JAMA. 2015; 313: 603-615
        • Cushman W.C.
        • Evans G.W.
        • Byington R.P.
        • Goff D.C.
        • Grimm R.H.
        • Cutler J.A.
        • et al.
        Effects of intensive blood-pressure control in type 2 diabetes mellitus.
        N. Engl. J. Med. 2010; 362: 1575-1585
        • Li W.
        • Katzmarzyk P.T.
        • Horswell R.
        • Wang Y.
        • Johnson J.
        • Hu G.
        Blood pressure and all-cause mortality among patients with type 2 diabetes.
        Int. J. Cardiol. 2016; 206: 116-121
        • Paulis L.
        • Steckelings U.M.
        • Unger T.
        Key advances in antihypertensive treatment.
        Nat. Rev. Cardiol. 2012; 9: 276-285
        • Nonogaki K.
        • Suzuki M.
        • Sanuki M.
        • Nonogaki N.
        • Takeda K.
        • Tsujita N.
        • Katoh S.
        • Kubota N.
        Low-frequency and very low-intensity ultrasound decreases blood pressure in subjects with hypertension.
        Int. J. Cardiol. 2013; 168: 1585-1586
        • Perin P.C.
        • Maule S.
        • Quadri R.
        Sympathetic nervous system, diabetes, and hypertension.
        Clin. Exp. Hypertens. 2001; 23: 45-55
        • Tam G.-M.
        • Yan B.P.
        • Shetty S.V.
        • Lam Y.-Y.
        Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
        Int. J. Cardiol. 2013; 164: 277-281
        • Coats A.J.
        • Cruickshank J.M.
        Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications.
        Int. J. Cardiol. 2014; 174: 702-709
        • Masuo K.
        • Rakugi H.
        • Ogihara T.
        • Esler M.D.
        • Lambert G.W.
        Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
        Curr. Diabetes Rev. 2010; 6: 58-67
        • Shewan L.G.
        • Coats A.J.
        Ethics in the authorship and publishing of scientific articles.
        Int. J. Cardiol. 2010; 144: 1-2